Trials / Conditions / Blast Crisis
Blast Crisis
4 registered clinical trials studyying Blast Crisis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies NCT01204164 | Tragara Pharmaceuticals, Inc. | Phase 1 |
| Completed | Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive NCT00763763 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intoleran NCT00101816 | Bristol-Myers Squibb | Phase 2 |
| Completed | Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701) NCT00034684 | Merck Sharp & Dohme LLC | Phase 1 / Phase 2 |